1st Quarter - Report
TIBER CREEK GROUP for LIFE TECHNOLOGIES CORPORATION
Firm
Income
$30,000
Expenses
—
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Laboratory testing in general. FDA regulations in general.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET MULLINS GRISSOM | — |
| CRISTINA KRASOW | — |
| ANDREW MCKECHNIE | Health Policy Advisor, Sen. Finance Committee |
| JEFFREY PECK | — |
Taxation/Internal Revenue Code TAX
Changes to tax code affecting corporate tax structure and international deferral.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DREW CANTOR | — |
| CRISTINA KRASOW | — |
| JUSTIN MCCARTHY | — |
| ANDREW MCKECHNIE | Health Policy Advisor, Sen. Finance Committee |
| JEFFREY PECK | — |
Budget/Appropriations BUD
FY13 Labor HHS appropriations, NIH funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA KRASOW | — |
| ANDREW MCKECHNIE | Health Policy Advisor, Sen. Finance Committee |
| JEFFREY PECK | — |
Science/Technology SCI
DNA testing in general. H.R. 988/S. 517, Katie Sepich Enhanced DNA Collection Act of 2011. Laboratory testing in general. FDA regulations in general.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA KRASOW | — |
| ANDREW MCKECHNIE | Health Policy Advisor, Sen. Finance Committee |
| JEFFREY PECK | — |
Law Enforcement/Crime/Criminal Justice LAW
DNA testing in general. H.R. 988/S. 517, the Katie Sepich Enhanced DNA Collection Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA KRASOW | — |
| ANDREW MCKECHNIE | Health Policy Advisor, Sen. Finance Committee |
| JEFFREY PECK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.